Skip to main content

and
  1. Article

    Open Access

    Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier

    Sarah Grasedieck, Afsaneh Panahi, Matthew C. Jarvis, Faezeh Borzooee in Leukemia (2024)

  2. Article

    Open Access

    Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis

    Protein synthesis is frequently deregulated during tumorigenesis. However, the precise contexts of selective translational control and the regulators of such mechanisms in cancer is poorly understood. Here, we...

    Maryam Ghashghaei, Yilin Liu, James Ettles, Giuseppe Bombaci in Nature Communications (2024)

  3. Article

    Open Access

    Elucidating the importance and regulation of key enhancers for human MEIS1 expression

    Myeloid ecotropic virus insertion site 1 (MEIS1) is essential for normal hematopoiesis and is a critical factor in the pathogenesis of a large subset of acute myeloid leukemia (AML). Despite the clinical relev...

    ** **ang, **ning Yang, Leo Escano, Ishpreet Dhillon, Edith Schneider in Leukemia (2022)

  4. No Access

    Chapter

    The Role of Stem Cell Transplant in the Therapy of Acute Myeloid Leukemia (AML)

    Acute myeloid leukemia (AML) is the most common indication for allogeneic hematopoietic stem cell transplant (HSCT). Decision-making around allogeneic HSCT for AML patients in first remission should be based o...

    David Sanford, Mahmoud Elsawy, Florian Kuchenbauer in Acute Leukemias (2021)

  5. No Access

    Article

    MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

    MicroRNAs (miRNAs) are commonly deregulated in acute myeloid leukemia (AML), affecting critical genes not only through direct targeting, but also through modulation of downstream effectors. Homeobox (Hox) genes b...

    Edith Schneider, Nicole Pochert, Christoph Ruess, Liam MacPhee, Leo Escano in Leukemia (2020)

  6. No Access

    Article

    Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

    Efficient and safe delivery of siRNA in vivo is the biggest roadblock to clinical translation of RNA interference (RNAi)-based therapeutics. To date, lipid nanoparticles (LNPs) have shown efficient delivery of...

    Nidhi Jyotsana, Amit Sharma, Anuhar Chaturvedi in Annals of Hematology (2019)

  7. No Access

    Article

    Revisiting thrombocytopenia in acute promyelocytic leukemia

    Florian Kuchenbauer, Christian Buske in Leukemia (2018)

  8. Article

    Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

    Nat. Med. 24, 282–291 (2018); published online 12 February 2018; corrected after print 6 March 2018 In the version of this article initially published, Omid Shah's name was misspelled as Omid Sha. The error ha...

    Nimitha R Mathew, Francis Baumgartner, Lukas Braun, David O'Sullivan in Nature Medicine (2018)

  9. No Access

    Article

    Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

    Combining the kinase inhibitor sorafenib with allogeneic stem cell transplantation boosts immune responses against a subtype of acute myelogenous leukemia, suggesting potential clinical benefit.

    Nimitha R Mathew, Francis Baumgartner, Lukas Braun, David O'Sullivan in Nature Medicine (2018)

  10. Article

    Open Access

    The non-coding RNA landscape of human hematopoiesis and leukemia

    Non-coding RNAs have emerged as crucial regulators of gene expression and cell fate decisions. However, their expression patterns and regulatory functions during normal and malignant human hematopoiesis are in...

    Adrian Schwarzer, Stephan Emmrich, Franziska Schmidt, Dominik Beck in Nature Communications (2017)

  11. No Access

    Protocol

    In Vivo Processing Assay Based on a Dual-Luciferase Reporter System to Evaluate DROSHA Enzymatic Activity

    Luciferase reporter assays are widely used to study promoter activity, transcription factors, intracellular signaling, protein interactions (Jia et al., PloS One 6:e26414), miRNA processing (Allegra and Merten...

    Vera Bilan, Danilo Allegra, Florian Kuchenbauer, Daniel Mertens in miRNA Maturation (2014)

  12. No Access

    Article

    The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells

    Mouse haematopoietic stem cells (HSCs) undergo a postnatal transition in several properties, including a marked reduction in their self-renewal activity. We now show that the developmentally timed change in th...

    Michael R. Copley, Sonja Babovic, Claudia Benz, David J. H. F. Knapp in Nature Cell Biology (2013)

  13. No Access

    Article

    Impact of serum storage conditions on microRNA stability

    S Grasedieck, N Schöler, M Bommer, J H Niess, H Tumani, A Rouhi, J Bloehdorn in Leukemia (2012)

  14. Article

    Circulating microRNAs as biomarkers - True Blood?

    MicroRNAs are post-transcriptional regulators that are involved in many physiological and pathophysiological conditions. A recent study compared the expression profiles of hundreds of blood-borne microRNAs acr...

    Nathalie Schöler, Christian Langer, Florian Kuchenbauer in Genome Medicine (2011)

  15. No Access

    Chapter

    MicroRNAs in Leukemia

    Deregulated gene expression plays a crucial role in leukemia and recent evidence suggests that in hematologic malignancies deregulated microRNAs (miRNAs) have the ability to function as both tumor suppressor a...

    Florian Kuchenbauer, Johannes Bloehdorn in MicroRNAs in Cancer Translational Research (2011)

  16. No Access

    Article

    Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

    Marco Marra and colleagues identify somatic mutations in EZH2 in diffuse large B-cell lymphomas and follicular lymphomas. EZH2 is a histone methyltransferase that participates in trimethylation of H3 Lys27 (H3K27...

    Ryan D Morin, Nathalie A Johnson, Tesa M Severson, Andrew J Mungall in Nature Genetics (2010)

  17. No Access

    Article

    Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

    For myelodysplastic syndromes caused by deletion of chromosome 5q, Daniel Starczynowski et al. provide evidence that decreased expression of two miRNAs in this region—miR-145 and miR-146a—contributes to abnormal ...

    Daniel T Starczynowski, Florian Kuchenbauer, Bob Argiropoulos in Nature Medicine (2010)

  18. No Access

    Article

    MiRNAs, epigenetics, and cancer

    By virtue of having multiple targets, a microRNA (miRNA) can have variable effects on oncogenesis by acting as tumor suppressor or oncogene in a context-dependent manner. Genome-wide epigenetic changes that oc...

    Arefeh Rouhi, Dixie L. Mager, R. Keith Humphries, Florian Kuchenbauer in Mammalian Genome (2008)